ArticleJID innovations : skin science from molecules to population health2021

Unlocking the Mechanisms of Cutaneous Adverse Drug Reactions: Activation of the Phosphatidylinositol 3-Kinase/Protein Kinase B Pathway by EGFR Inhibitors Triggers Keratinocyte Differentiation and Polarization of Epidermal Immune Responses.

Thomas Ondet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.